Arkadiusz Dudek, MD [clinicaltrials_resource:7ffbf0d45abf1ca9b25001beeb16427f]
clinicaltrials:NCT00365547clinicaltrials:NCT00620295clinicaltrials:NCT00622674clinicaltrials:NCT00726739Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00748163]clinicaltrials:NCT01056601
overall official [clinicaltrials_vocabulary:overall-official]
Arkadiusz Dudek, MD [clinicaltrials_resource:7ffbf0d45abf1ca9b25001beeb16427f]
Bio2RDF identifier
7ffbf0d45abf1ca9b25001beeb16427f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7ffbf0d45abf1ca9b25001beeb16427f
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
dudek002@umn.edu
last name [clinicaltrials_vocabulary:last-name]
Arkadiusz Dudek, MD
phone [clinicaltrials_vocabulary:phone]
612-624-0123
role [clinicaltrials_vocabulary:role]
Principal Investigator
identifier
clinicaltrials_resource:7ffbf0d45abf1ca9b25001beeb16427f
title
Arkadiusz Dudek, MD
@en
type
label
Arkadiusz Dudek, MD [clinicaltrials_resource:7ffbf0d45abf1ca9b25001beeb16427f]
@en